Floatz logo

Finasteride

Prostatic Hyperplasia

Turku University HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Prostatic Hyperplasia cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
University of Florence
Phase 4BB
Degarelix
Turku University Hospital
Phase 4BB
Sinecatechins
H. Lee Moffitt Cancer Center and Research Institute
Phase 2CCC
Papaverine
Manchanda Medical Clinic
Early Phase 1C

Same molecule, other indications

Finasteride is also rated in:

prostate cancerDormant
BB
Indicative ·
64 / 100
View asset →
prostate intraepithelial neoplasiaDormant
B
Indicative ·
61 / 100
View asset →
prostate adenocarcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →